Diastolic Perfusion Pressure Predicts Response to Inotropes and Vasopressors and Benefit From Mechanical Circulatory Support in Cardiogenic Shock
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F25%3A10498036" target="_blank" >RIV/00669806:_____/25:10498036 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/25:10498036 RIV/00216208:11130/25:10498036 RIV/00216208:11140/25:10498036 RIV/00064203:_____/25:10498036 RIV/00064165:_____/25:10498036
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=esiWUxN04H" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=esiWUxN04H</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1161/CIRCHEARTFAILURE.125.012847" target="_blank" >10.1161/CIRCHEARTFAILURE.125.012847</a>
Alternative languages
Result language
angličtina
Original language name
Diastolic Perfusion Pressure Predicts Response to Inotropes and Vasopressors and Benefit From Mechanical Circulatory Support in Cardiogenic Shock
Original language description
BACKGROUND: Hemodynamic response to escalation of vasoactive drugs has not been well-characterized in patients with cardiogenic shock (CS). We tested the hypothesis that lower diastolic perfusion pressure (DPP=diastolic blood pressure-right atrial pressure) was associated with more limited hemodynamic response to uptitration of vasoactive drugs and with possible benefit from early mechanical circulatory support in patients with CS. METHODS: This study consisted of 2 parts: (1) we evaluated the relationship between baseline DPP and changes in cardiac power output index (CPOI) in response to increase in vasoactive drugs in a cohort of patients with CS (n=93) and (2) we compared all-cause mortality based on baseline DPP in a post hoc analysis of the ECMO-CS trial (Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock). CPOI responders were defined as postescalation CPOI >=0.28 W/m(2). RESULTS: Vasoactive inotrope score escalated from 11.2+-3.9 to 24.5+-4.7. Escalation of vasoactive drugs was associated with increases in CPOI to 0.23+-0.06 W/m(2) (all P<0.001). Postescalation CPOI was directly related to baseline cardiac index and DPP. Baseline DPP discriminated CPO responders from nonresponders with an optimal cutoff of 37 mm Hg. Patients with baseline DPP >=37 mm Hg had greater CPOI increase and lactate clearance. In the ECMO-CS trial, patients with DPP <37 mm Hg had lower mortality (hazard ratio, 0.37 [95% CI, 0.14-0.97]; P=0.044) with immediate venoarterial extracorporeal membrane oxygenation compared with early conservative management but no significant difference in the subgroup with DPP >=37 mm Hg. CONCLUSIONS: Lower DPP was associated with more limited hemodynamic response to escalation of vasoactive drugs and potentially greater benefit from early venoarterial extracorporeal membrane oxygenation in CS.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/NV15-27994A" target="_blank" >NV15-27994A: ExtraCorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (the ECMO-CS trial)</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Circulation: Heart Failure
ISSN
1941-3289
e-ISSN
1941-3297
Volume of the periodical
18
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
e012847
UT code for WoS article
001525800900001
EID of the result in the Scopus database
2-s2.0-105005463761